TY - JOUR
T1 - Geroprotectors.org
T2 - A new, structured and curated database of current therapeutic interventions in aging and age-related disease
AU - Moskalev, Alexey
AU - Chernyagina, Elizaveta
AU - de Magalhães, João Pedro
AU - Barardo, Diogo
AU - Thoppil, Harikrishnan
AU - Shaposhnikov, Mikhail
AU - Budovsky, Arie
AU - Fraifeld, Vadim E.
AU - Garazha, Andrew
AU - Tsvetkov, Vasily
AU - Bronovitsky, Evgeny
AU - Bogomolov, Vladislav
AU - Scerbacov, Alexei
AU - Kuryan, Oleg
AU - Gurinovich, Roman
AU - Jellen, Leslie C.
AU - Kennedy, Brian
AU - Mamoshina, Polina
AU - Dobrovolskaya, Evgeniya
AU - Aliper, Alex
AU - Kaminsky, Dmitry
AU - Zhavoronkov, Alex
PY - 2015/1/1
Y1 - 2015/1/1
N2 - As the level of interest in aging research increases, there is a growing number of geroprotectors, or therapeutic interventions that aim to extend the healthy lifespan and repair or reduce aging-related damage in model organisms and, eventually, in humans. There is a clear need for a manually-curated database of geroprotectors to compile and index their effects on aging and age-related diseases and link these effects to relevant studies and multiple biochemical and drug databases. Here, we introduce the first such resource, Geroprotectors (http://geroprotectors.org). Geroprotectors is a public, rapidly explorable database that catalogs over 250 experiments involving over 200 known or candidate geroprotectors that extend lifespan in model organisms. Each compound has a comprehensive profile complete with biochemistry, mechanisms, and lifespan effects in various model organisms, along with information ranging from chemical structure, side effects, and toxicity to FDA drug status. These are presented in a visually intuitive, efficient framework fit for casual browsing or in-depth research alike. Data are linked to the source studies or databases, providing quick and convenient access to original data. The Geroprotectors database facilitates cross-study, cross-organism, and cross-discipline analysis and saves countless hours of inefficient literature and web searching. Geroprotectors is a onestop, knowledge-sharing, time-saving resource for researchers seeking healthy aging solutions.
AB - As the level of interest in aging research increases, there is a growing number of geroprotectors, or therapeutic interventions that aim to extend the healthy lifespan and repair or reduce aging-related damage in model organisms and, eventually, in humans. There is a clear need for a manually-curated database of geroprotectors to compile and index their effects on aging and age-related diseases and link these effects to relevant studies and multiple biochemical and drug databases. Here, we introduce the first such resource, Geroprotectors (http://geroprotectors.org). Geroprotectors is a public, rapidly explorable database that catalogs over 250 experiments involving over 200 known or candidate geroprotectors that extend lifespan in model organisms. Each compound has a comprehensive profile complete with biochemistry, mechanisms, and lifespan effects in various model organisms, along with information ranging from chemical structure, side effects, and toxicity to FDA drug status. These are presented in a visually intuitive, efficient framework fit for casual browsing or in-depth research alike. Data are linked to the source studies or databases, providing quick and convenient access to original data. The Geroprotectors database facilitates cross-study, cross-organism, and cross-discipline analysis and saves countless hours of inefficient literature and web searching. Geroprotectors is a onestop, knowledge-sharing, time-saving resource for researchers seeking healthy aging solutions.
KW - Aging
KW - Body composition
KW - Frailty
KW - Growth hormone receptor (GHR)
KW - Lifespan
KW - Muscle-specific knockout
KW - Pathology
UR - http://www.scopus.com/inward/record.url?scp=84943380700&partnerID=8YFLogxK
U2 - 10.18632/aging.100799
DO - 10.18632/aging.100799
M3 - Article
AN - SCOPUS:84943380700
SN - 1945-4589
VL - 7
SP - 616
EP - 628
JO - Aging
JF - Aging
IS - 9
ER -